ShockWave Medical (SWAV) Revenue & Revenue Breakdown
ShockWave Medical Revenue Highlights
Latest Revenue (Y)
$730.23M
Latest Revenue (Q)
$218.81M
Main Segment (Y)
Coronary
Main Geography (Y)
UNITED STATES
ShockWave Medical Revenue by Period
ShockWave Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $730.23M | 49.11% |
| 2022-12-31 | $489.73M | 106.51% |
| 2021-12-31 | $237.15M | 249.83% |
| 2020-12-31 | $67.79M | 57.92% |
| 2019-12-31 | $42.93M | 250.05% |
| 2018-12-31 | $12.26M | 613.38% |
| 2017-12-31 | $1.72M | - |
ShockWave Medical generated $730.23M in revenue during NA 2023, up 49.11% compared to the previous quarter, and up 5954.74% compared to the same period a year ago.
ShockWave Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $218.81M | 7.80% |
| 2023-12-31 | $202.98M | 9.12% |
| 2023-09-30 | $186.02M | 3.25% |
| 2023-06-30 | $180.16M | 11.86% |
| 2023-03-31 | $161.07M | 11.83% |
| 2022-12-31 | $144.03M | 9.67% |
| 2022-09-30 | $131.33M | 8.77% |
| 2022-06-30 | $120.75M | 28.96% |
| 2022-03-31 | $93.63M | 11.22% |
| 2021-12-31 | $84.18M | 29.20% |
| 2021-09-30 | $65.16M | 16.54% |
| 2021-06-30 | $55.91M | 75.26% |
| 2021-03-31 | $31.90M | 40.43% |
| 2020-12-31 | $22.72M | 15.96% |
| 2020-09-30 | $19.59M | 90.45% |
| 2020-06-30 | $10.29M | -32.32% |
| 2020-03-31 | $15.20M | 6.18% |
| 2019-12-31 | $14.31M | 26.29% |
| 2019-09-30 | $11.33M | 13.19% |
| 2019-06-30 | $10.01M | 37.74% |
| 2019-03-31 | $7.27M | 43.60% |
| 2018-12-31 | $5.06M | 40.61% |
| 2018-09-30 | $3.60M | 57.96% |
| 2018-06-30 | $2.28M | 72.39% |
| 2018-03-31 | $1.32M | - |
ShockWave Medical generated $218.81M in revenue during Q1 2024, up 7.80% compared to the previous quarter, and up 151.92% compared to the same period a year ago.
ShockWave Medical Revenue Breakdown
ShockWave Medical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|
| Other Product Line | $2.67M | $3.59M | $1.62M | $1.21M |
| Peripheral | $194.35M | $132.28M | $74.06M | $41.99M |
| Coronary | $528.85M | $353.86M | $161.46M | $24.59M |
ShockWave Medical's latest annual revenue breakdown by segment (product or service), as of Dec 23: Coronary (72.86%), Peripheral (26.77%), and Other Product Line (0.37%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Peripheral | $51.84M | $48.12M | $47.84M | $52.26M | $46.13M | $40.50M | $37.05M | $31.89M | $22.85M | $21.41M | $17.73M | $18.79M | $16.14M |
| Product and Service, Other | $599.00K | $572.00K | $895.00K | $1.06M | $1.24M | $1.03M | $442.00K | - | - | - | - | - | - |
| Coronary | $164.53M | $152.87M | $136.32M | $125.78M | $113.88M | $102.65M | $93.04M | $87.83M | $70.34M | $62.29M | $47.16M | $36.70M | $15.31M |
| Other Product Line | - | - | - | - | - | - | - | - | - | $490.00K | $265.00K | $413.00K | $451.00K |
ShockWave Medical's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Coronary (75.83%), Peripheral (23.89%), and Product and Service, Other (0.28%).
ShockWave Medical Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| UNITED STATES | $581.55M | $407.43M | $186.32M | $37.12M | $22.70M |
| All Other Countries | $71.17M | $31.30M | $12.25M | $7.21M | $2.73M |
| Europe | $77.52M | $51.01M | $38.57M | - | - |
| Rest Of Europe | - | - | - | $19.14M | $14.10M |
| GERMANY | - | - | - | $4.31M | $3.40M |
ShockWave Medical's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (79.64%), Europe (10.62%), and All Other Countries (9.75%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe | $26.26M | $23.01M | $19.35M | $18.91M | $16.23M | $13.79M | $11.76M | $13.39M | $12.07M | $11.30M | $8.62M | $10.42M | - | - | - | - | - | - | - | - |
| All Other Countries | $17.01M | $21.88M | $19.77M | $16.31M | $13.21M | $11.93M | $9.07M | $7.26M | $3.04M | $3.28M | $3.76M | $2.58M | $2.63M | $3.32M | $1.67M | $817.00K | $1.41M | $1.03M | $786.00K | $658.00K |
| UNITED STATES | $175.53M | $158.09M | $146.90M | $144.94M | $131.62M | $118.31M | $110.50M | $100.10M | $78.52M | $69.59M | $42.91M | $21.05M | $12.67M | $11.14M | $5.54M | $7.77M | $7.64M | $6.25M | $5.17M | - |
| U S | - | - | - | - | - | - | - | - | - | - | $52.77M | - | - | - | - | - | - | - | - | - |
| Rest Of Europe | - | - | - | - | - | - | - | - | - | - | - | - | $6.91M | $5.33M | $5.59M | $3.11M | $5.11M | $4.62M | $3.43M | $3.31M |
| GERMANY | - | - | - | - | - | - | - | - | - | - | - | - | $1.31M | $1.39M | $1.19M | $825.00K | $911.00K | $1.01M | $873.00K | $873.00K |
ShockWave Medical's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (80.22%), Europe (12.00%), and All Other Countries (7.77%).
ShockWave Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SYK | Stryker | $20.50B | $5.42B |
| EW | Edwards Lifesciences | $6.00B | $1.39B |
| ALGN | Align | $3.86B | $1.03B |
| DXCM | DexCom | $3.62B | $1.00B |
| MASI | Masimo | $2.05B | $492.80M |
| PODD | Insulet | $1.70B | $488.50M |
| PEN | Penumbra | $1.06B | $299.40M |
| TNDM | Tandem Diabetes Care | $747.72M | $331.03M |
| SWAV | ShockWave Medical | $730.23M | $218.81M |
| INSP | Inspire Medical Systems | $624.80M | $195.88M |
| NARI | Inari Medical | $493.63M | $145.82M |
| TMDX | TransMedics Group | $241.62M | $114.31M |
| OM | Outset Medical | $130.38M | $27.39M |
| CLPT | ClearPoint Neuro | $23.95M | $7.86M |
SWAV Revenue FAQ
What is ShockWave Medical’s yearly revenue?
ShockWave Medical's yearly revenue for 2023 was $730.23M, representing an increase of 49.11% compared to 2022. The company's yearly revenue for 2022 was $489.73M, representing an increase of 106.51% compared to 2021. SWAV's yearly revenue for 2021 was $237.15M, representing an increase of 249.83% compared to 2020.
What is ShockWave Medical’s quarterly revenue?
ShockWave Medical's quarterly revenue for Q1 2024 was $218.8M, a 7.80% increase from the previous quarter (Q4 2023), and a 35.85% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $202.98M, a 9.12% increase from the previous quarter (Q3 2023), and a 40.93% increase year-over-year (Q4 2022). SWAV's quarterly revenue for Q3 2023 was $186.02M, a 3.25% increase from the previous quarter (Q2 2023), and a 41.64% increase year-over-year (Q3 2022).
What is ShockWave Medical’s revenue growth rate?
ShockWave Medical's revenue growth rate for the last 3 years (2021-2023) was 207.92%, and for the last 5 years (2019-2023) was 1601.10%.
What are ShockWave Medical’s revenue streams?
ShockWave Medical's revenue streams in c 23 are Other Product Line, Peripheral, and Coronary. Other Product Line generated $2.67M in revenue, accounting 0.37% of the company's total revenue, down -25.60% year-over-year. Peripheral generated $194.35M in revenue, accounting 26.77% of the company's total revenue, up 46.92% year-over-year. Coronary generated $528.84M in revenue, accounting 72.86% of the company's total revenue, up 49.45% year-over-year.
What is ShockWave Medical’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of ShockWave Medical was Coronary. This segment made a revenue of $528.84M, representing 72.86% of the company's total revenue.